AMBUSH 25W Insecticide Wettable Powder; AMBUSH

AMVAC CHEMICAL CORPORATION

Revision date : 2010-06-16

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

52645-53-1

Name of the chemical

Permethrin

Concentration

N/A

EC/CAS

7631-86-9

Name of the chemical

Silver adsorbed on silicon dioxide

Concentration

N/A

General Information

Revision date

2010-06-16

Product name

AMBUSH 25W Insecticide Wettable Powder; AMBUSH

Manufacturer Name

AMVAC CHEMICAL CORPORATION

Emergency telephone

323-264-3910

Icons in SDS

Company Information

company name

AMVAC CHEMICAL CORPORATION

Section 2

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: CAUTION: May cause eye and skin irritation. Harmful if swallowed. Avoid inhaling dust. Do not contaminate feed or foodstuffs. KEEP OUT OF REACH OF CHILDREN. Toxic to fish and aquatic organisms.

Principle Routes of Exposure

Ingestion, inhalation, eye contact, and skin contact SIGNS OF ACUTE OVEREXPOSURE: A person suffering from acute exposure to this product may suffer from mild eye irritation. In addition, exposure to Permethrin may induce adverse effects on the nervous system. Symptoms include hypersensitivity, tremors, unsteady gait, and salivation. Other possible signs of overexposure include facial erythema (flushing) and facial skin tingling. SIGNS OF CHRONIC OVEREXPOSURE: Prolonged exposure to high atmospheric concentrations of respirable dust of amorphous silica may cause non-progressive fibrosis of the lungs; amorphous silica does not cause silicosis. OTHER POTENTIAL HEALTH EFFECTS: No evidence of mutagenic or teratogenic potential has been observed. EPA (2004) has evaluated the carcinogenic potential of Permethrin under its ‘Review Draft of the Guidelines fro Carcinogen Risk Assessment (1999)’. Permethrin has suggestive evidence of carcinogenicity but not sufficient to assess human carcinogenic potential.

Medical Conditions Generally Aggravated by Exposure

None known CARE SHOULD BE EXERCISED IN HANDLING PERMETHRIN AND ITS FORMULATIONS

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.